BILYPSA (Saroglitazar (4mg))

Bilypsa Tablet is indicated for the management of Noncirrhotic Non-Alcoholic Steatohepatitis and Non-Alcoholic Fatty Liver Disease (NAFLD) that may have accompanying conditions such as obesity, Type 2 Diabetes Mellitus, Dyslipidemia, or Metabolic Syndrome, as well as for addressing elevated cholesterol levels in diabetic patients (known as diabetic dyslipidemia). This medication can be taken with or without food, ideally at the same time each day to maximize its effectiveness. It is crucial to continue the medication until advised otherwise by a healthcare provider. Maintaining adherence to a prescribed diet and exercise regimen is essential while undergoing treatment with this medication, as lifestyle factors are instrumental in achieving a healthy weight and safeguarding liver health. Typical adverse reactions associated with this medication include gas, digestive discomfort, bloating, elevated body temperature, and fatigue. These effects are generally mild and temporary. If you find these symptoms distressing or if they persist, it is advisable to consult your healthcare provider. Prior to initiating therapy with this medication, it is important to inform your doctor if you have a history of kidney issues, heart complications, or pancreas disorders, or if you consume alcohol regularly. Pregnant or nursing individuals should seek medical advice before using this treatment, and be aware that other concurrent medications may interact with it. Regular assessments, including liver function tests, kidney function evaluations, and blood glucose monitoring may be necessary to ensure the medication is functioning effectively.